Chat with us in Facebook Messenger. Find out what's happening in the world as it unfolds.

Researcher Shruti Dave examines stem cells through a microscope at the Transplantation Biology Research Centre situated at The Institute of Kidney Disease and Research Centre (IKDRC), Civil Hospital campus in Ahmedabad on February 6, 2013.  Shruti Dave, working as a junior research fellow under Doctor Aruna Vanikar and Prof H L Trivedi at the department of Pathology, IKDRC-ITS, was conferred the most outstanding young researcher in Nephrology award for her work on generation of regulatory-cells from adipose tissue and peripheral blood mononuclear cells, by TANKER Foundation and Kerala Kidney Research Foundation in Chennai.     AFP PHOTO / Sam PANTHAKY        (Photo credit should read SAM PANTHAKY/AFP/Getty Images)
Researcher Shruti Dave examines stem cells through a microscope at the Transplantation Biology Research Centre situated at The Institute of Kidney Disease and Research Centre (IKDRC), Civil Hospital campus in Ahmedabad on February 6, 2013.  Shruti Dave, working as a junior research fellow under Doctor Aruna Vanikar and Prof H L Trivedi at the department of Pathology, IKDRC-ITS, was conferred the most outstanding young researcher in Nephrology award for her work on generation of regulatory-cells from adipose tissue and peripheral blood mononuclear cells, by TANKER Foundation and Kerala Kidney Research Foundation in Chennai.     AFP PHOTO / Sam PANTHAKY        (Photo credit should read SAM PANTHAKY/AFP/Getty Images)

    JUST WATCHED

    #LaCifraDelDía: 475.000 dólares, lo que cuesta el último tratamiento contra el cáncer

MUST WATCH

#LaCifraDelDía: 475.000 dólares, lo que cuesta el último tratamiento contra el cáncer

Un tratamiento contra el cáncer, que costará 475.000 dólares, entrenará a las células del paciente para "reconocer y atacar la enfermedad".

#LaCifraDelDía: 475.000 dólares, lo que cuesta el último tratamiento contra el cáncer

Un tratamiento contra el cáncer, que costará 475.000 dólares, entrenará a las células del paciente para "reconocer y atacar la enfermedad".